Slide 1: First Quarter 2024 Earnings
Click Here to Edit Title First Quarter 2024 Earnings April 24, 2024
Slide 2: Cautionary Statement
Click Here to Cautionary Statement Edit Title Cautionary Statement Under the Private Securities Litigation Reform Act; Non-GAAP Measures This presentation contains “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements ma
Slide 3: IDEX Overview
Click Here IDEX Overview to Edit Title First Quarter Results Solid execution and strong cash generation Sequential orders lift in Industrials & Water Differing rates of recovery in HST targeted markets Dispensing better performance than expected Looking Ahead • Strength in Water due to globa
Slide 4: Q1 2024 Financial Performance
Click Q1 2024 HereFinancial to Edit Title Performance ($ in millions excl. EPS) Sales Adj. EBITDA Margin* Adj. EPS* Free Cash Flow* -6% Organic* -120 bps -10% +13% $845 27.2% 26.0% $801 $137 $2.09 $1.88 $121 Q1'23 Q1'24 Q1'23 Q1'24 Q1'23 Q1'24 Q1'23 Q1'24 Organic FX M&A YoY∆ Sales Growth -6% - 1% -5
Slide 5: Adjusted EBITDA Walk
Click Q1 2024 Here Adjusted to Edit Title EBITDA Walk ($ in millions) 1Q’23 Act Organic Flow Price / Mix Resource Acq / Div / FX 1Q’24 ACT Adj. EBITDA Thru Productivity / Investment / Adj. EBITDA Inflation Discretionary Flow thru @ Organic flow Total flow PY GM%* thru** through 45.2% (50%) (48%) **E
Slide 6: Q1 2024: Fluid & Metering Technologies
Click Q1 2024: HereFluid to Edit & Metering Title Technologies ($ in millions) Orders Sales Adj. EBITDA Margin* Highlights -7% Organic* -3% Organic* +60 bps • Water project timing headwind • Energy market remains stable $322 $314 33.6% • Ag cyclically down $336 33.0% $314 • Profitability improvement
Slide 7: Q1 2024: Health & Science Technologies
Click Q1 2024: HereHealth to Edit&Title Science Technologies ($ in millions) Orders Sales Adj. EBITDA Margin* Highlights -2% Organic* -13% Organic* -250 bps • Life Science / Analytical Instrumentation in line with expectation $318 $314 • Semiconductor improving $351 28.7% $310 26.2% • Industrials st
Slide 8: Q1 2024: Fire & Safety / Diversified Products
Click Q1 2024: HereFire to Edit & Safety Title / Diversified Products ($ in millions) Orders Sales Adj. EBITDA Margin* Highlights +10% Organic* +2% Organic* +40 bps • Dispensing project wins in emerging markets $178 • Stability in Fire & Rescue $174 28.5% 28.9% $194 • BAND-IT strength in automotive
Slide 9: 2024 Guidance Summary
Click Here 2024 Guidance to Edit Summary Title Second Quarter Full Year Current Guidance Current Guidance Revenue % vs Prior Year Organic* (3%) – (2%) 0% - 2% growth EBITDA % Adjusted* ~27.5% ~28% Earnings Per Share Reported* $1.75 - $1.80 $7.13 - $7.43 Earnings Per Share Adjusted* $2.00 - $2.05 $8.
Slide 10: IDEX Value Drivers
IDEX Value Drivers ORGANIC INORGANIC MARGIN GROWTH GROWTH EXPANSION • Leading market entitlement • Strong funnel of M&A opportunities • Leading the IDEX Op Model • Pricing Execution • Fast growing companies • 80/20 • Growth Bets Prioritization • Disciplined capital deployment • Leverage
Slide 11: Non-GAAP Reconciliations
Click Here to Edit Title Non-GAAP Reconciliations
Slide 12: Reconciliations of Net Sales, Gross Profit and Net Income
Table 1: Reconciliations of the Change in Net Sales to Organic Net Sales Three Months Ended March 31, 2024 FMT HST FSDP IDEX Change in net sales (3%) (12%) 2% (5%) Less: Net impact from acquisitions/divestitures(1) —% 1% —% 1% Impact from foreign currency —% —% —% —% Change in organic net sales (3%)
Slide 13: Reconciliation of Net Income to Adjusted EBITDA
Table 4: Reconciliations of Net Income to Adjusted EBITDA (dollars in millions) Three Months Ended March 31, 2024 2023 FMT HST FSDP Corporate IDEX FMT HST FSDP Corporate IDEX Reported net income $ — $ — $ — $ — $ 121.3 $ — $ — $ — $ — $ 139.8 Provision for income taxes — — — — 33.2 — — — — 40.0 Inte
Slide 14: Reconciliation of Estimated 2024 Diluted EPS to Adjusted EPS
Table 7: Reconciliation of Estimated 2024 Diluted EPS Attributable to IDEX to Adjusted Diluted EPS Attributable to IDEX Guidance Second Quarter 2024 Full Year 2024 Estimated diluted EPS attributable to IDEX $1.75 - $1.80 $7.13 - $7.43 Fair value inventory step-up charge — 0.03 Tax impact on fair val